The Company invites individual and institutional investors, as well as advisors and analysts, to attendonlineatVirtualInvestorConferences.com
Kelyniam Global(OTC:KLYG),amakerofcustomcranial implants,today announced that Terrance Kurtenbach, CFO, will present live at the Life Sciences Virtual Investor Forum hostedby VirtualInvestorConferences.com, on September 18th, 2025
DATE:September 18thTIME: 10:00 EDTLINK:EventDetails
Company management will be available for 1×1 meetings: September 18 (PM), 19, 22.Please usethelinkaboveforscheduling.
Thiswillbealive,interactiveonlineeventwhereinvestorsareinvitedtoaskthecompany questionsinreal-time.Ifattendeesarenotabletojointheeventliveonthedayofthe conference,anarchivedwebcastwillalsobemadeavailableaftertheevent.
Itisrecommendedthatonlineinvestorspre-registerandruntheonlinesystemcheckto expedite participationandreceiveeventupdates.
Learnmoreabouttheeventatwww.virtualinvestorconferences.com.
Kelyniam hasbothsalesmomentumandadditionalproductlineenhancementstopresentto thecurrentmarket.Surgeonswholiketheosteointegrative benefitsofimplants canfind similar or better results with the CustomizedBoneï” (hydroxyapatite) implant Kelyniam licensed exclusively from Finceramica Spa of Italy.Together with the OsteoStripï” and Osteoplugï” product lines from Osteopore, Singapore, Kelyniam is well positioned to become the leader in regenerative optionsforU.S.surgeons.
AboutKelyniamKelyniam Inc., specializes in the rapid production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The Company develops, manufactures, and distributes custom cranial implants for patients. Kelyniam works directly with surgeons, health systems and payors to improve clinical and cost-of-care outcomes. Kelyniam's web site addressiswww.Kelyniam.com.
As a cautionary note to investors, certain matters discussed in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; changes in the status of ability to market products; and the risks described from time to time in the Company's SEC reports
About Virtual Investor Conferences®Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access.Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content.Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
https://edge.prnewswire.com/c/img/favicon.png?sn=NY73036&sd=2025-09-15
View original content:https://www.prnewswire.com/news-releases/kelyniam-global-inc-to-present-at-the-life-sciences-virtual-investor-forum-september-18th-302555870.html
SOURCE Kelyniam Global Inc
https://rt.newswire.ca/rt.gif?NewsItemId=NY73036&Transmission_Id=202509150001PR_NEWS_USPR_____NY73036&DateId=20250915